StockData

TFA Therapeutics, Inc. (RAJAF) stock

RAJAFOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on May 15, 2026Score 7/30
$9.18+0.00 (0.00%)

Close on Oct 16, 2026Market cap –P/E –Yield –

TFA Therapeutics net income

Net income is the profit left for shareholders after every expense, interest and tax.

TFA Therapeutics's net income for the twelve months ending Dec 31, 2023 was $751.61K. For fiscal 2025 it was -$154.82K. The highest annual figure on record is $751.61K in fiscal 2023.

Annual net income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$154.82K–
FY2024Dec 31, 2024-$226.26K-130.1%
FY2023Dec 31, 2023$751.61K–
FY2022Dec 31, 2022-$720.09K–
FY2021Dec 31, 2021-$491.01K–

Quarterly net income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q4 FY2023Dec 31, 2023$901.17K–
Q4 FY2022Dec 31, 2022-$77.05K–

More TFA Therapeutics figures

See a number that looks wrong?